Vernal’s mRNA platform manufacturing capabilities have gotten the attention of the mRNA community. Read Pharma’s Almanac’s expose on Vernal here: Platform Processes and End-to-End Capabilities Position Vernal Biosciences as a Critical CDMO Resource for mRNA Developers (pharmasalmanac.com)
Seven Days wrote a great follow up article on Vernal’s growth since the summer of 2021. Click the link below to see what we’ve been up to. What a difference a year makes! New Companies Are Riding Vermont’s Health Tech…
Vernal is proud to be the Silver Sponsor for this exciting event! Connect with one of Vernal’s experts on November 8-10, 2022 in Boston and meet them at our booth for discussions about your mRNA and LNP projects. Schedule a…
Vernal Biosciences is excited to announce the start of construction on its new, 23,000 square foot mRNA manufacturing facility in Essex Junction, Vt. The new facility will include state-of-the-art equipment and clean rooms to support clinical mRNA and LNP mRNA…
Local NBC affiliate NBC5 came to visit Vernal Bioscience to discuss the eventual move to a new, larger facility in Essex and our plans to nearly quadruple our workforce. Watch the story on NBC5.
Vernal produces high-purity mRNA to supply to companies that develop mRNA-based health treatments. Read the full story at VTDigger.